E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc

Lijia Zhong1, Yuanyuan Zhang1, Mengyao Li1

  • 1Department of Pulmonology, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.

Aging
|December 1, 2020
PubMed

Insights

FBXW7 (F-box and leucine-rich repeat protein WWOX domain-containing protein 7) suppresses M2 macrophage polarization, limiting tumor progression. Its deficiency promotes M2-like tumor-associated macrophages and enhances tumor growth, offering new immunotherapy targets.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • FBXW7 (F-box and leucine-rich repeat protein WWOX domain-containing protein 7) is an E3 ubiquitin ligase crucial for degrading oncoproteins in cancer cells.
  • The role of FBXW7 in macrophages and the tumor immune microenvironment remains largely unexplored.
  • Tumor-associated macrophages (TAMs) significantly influence tumor progression and the immune response.

Purpose of the Study:

  • To investigate the function of FBXW7 in macrophage polarization within the tumor immune microenvironment.
  • To elucidate the impact of FBXW7 on M2-like TAM polarization and its role in limiting tumor progression.

Main Methods:

  • Utilized myeloid FBXW7-deficient mice and Lewis lung carcinoma cells (LLCs) for in vivo tumor growth studies.
  • Performed in vitro experiments stimulating FBXW7-knockout macrophages with LLCs supernatant.
  • Investigated the underlying molecular mechanism involving c-Myc degradation via the ubiquitin-proteasome system.

Main Results:

  • Myeloid FBXW7 deficiency led to increased M2-like TAMs and aggravated tumor growth in mice.
  • FBXW7-knockout macrophages exhibited enhanced M2 polarization and promoted cancer cell growth in vitro.
  • FBXW7 was confirmed to inhibit M2-like TAM polarization by mediating c-Myc degradation.

Conclusions:

  • FBXW7 plays a critical role in suppressing M2-like TAM polarization, thereby limiting tumor progression.
  • FBXW7 deficiency promotes a pro-tumorigenic M2 TAM phenotype.
  • Targeting FBXW7 may offer novel strategies for cancer immunotherapy by modulating TAM polarization.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.5K